Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1

被引:26
作者
Jenson, H
McIntosh, K
Pitt, J
Husak, S
Tan, M
Bryson, Y
Easley, K
Shearer, W
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pediat, Div Infect Dis, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Microbiol, Div Infect Dis, San Antonio, TX 78284 USA
[3] Texas Childrens Hosp, Baylor Coll Med, Dept Allergy & Immunol, Houston, TX 77030 USA
[4] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA
[5] Columbia Univ Coll Phys & Surg, Dept Pediat, Div Infect Dis, New York, NY 10032 USA
[6] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA
[7] Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA
关键词
D O I
10.1086/314764
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The natural history of Epstein-Barr virus (EBV) infection in 556 infants born to 517 human immunodeficiency virus (HIV) type I-infected mothers was studied in a prospective, multicenter, cohort study. HIV-1-infected children had a cumulative EBV infection rate similar to HIV-1-uninfected children at age 3 years (77.8% vs. 84.9%) but had more frequent oropharyngeal EBV shedding (50.4% vs. 28.2%; P <.001), The probability of shedding decreased with longer time from EBV seroconversion and was similar to that of HIV-1-uninfected children 3 years after seroconversion, HIV-1-infected children identified as rapid progressors shed EBV more frequently than nonrapid progressors (69.4% vs. 41.0%; P =.01), HIV-1-infected children with EBV infection had higher mean CD8 cell counts. EBV infection did not have an independent effect on mean CD4 cell counts, percent CD4, IgG levels, HIV-1 RNA levels, lymphadenopathy, hepatomegaly, or splenomegaly, Early EBV infection is common in children born to HIV-1-infected mothers. Children with rapidly progressive HIV-1 disease have more frequent EBV shedding.
引用
收藏
页码:1395 / 1404
页数:10
相关论文
共 49 条
[21]   AN EPSTEIN-BARR VIRUS IMMEDIATE-EARLY GENE-PRODUCT TRANS-ACTIVATES GENE-EXPRESSION FROM THE HUMAN IMMUNODEFICIENCY VIRUS LONG TERMINAL REPEAT [J].
KENNEY, S ;
KAMINE, J ;
MARKOVITZ, D ;
FENRICK, R ;
PAGANO, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1652-1656
[22]   HIGH TITERS OF EPSTEIN-BARR-VIRUS ANTIBODIES IN ADULT PATIENTS WITH LYMPHOCYTIC INTERSTITIAL PNEUMONITIS ASSOCIATED WITH AIDS [J].
KRAMER, MR ;
SALDANA, MJ ;
RAMOS, M ;
PITCHENIK, AE .
RESPIRATORY MEDICINE, 1992, 86 (01) :49-52
[23]   EPSTEIN-BARR VIRUS-INFECTIONS DURING PREGNANCY - A PROSPECTIVE-STUDY AND REVIEW OF THE LITERATURE [J].
LE, CT ;
CHANG, RS ;
LIPSON, MH .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1983, 137 (05) :466-468
[24]  
Lennette ET, 1995, DIAGNOSTIC PROCEDURE, P299
[25]   LYMPHOMA COMPLICATING IMMUNODEFICIENCY DISORDERS [J].
LEVINE, AM .
ANNALS OF ONCOLOGY, 1994, 5 :S29-S35
[26]   EPSTEIN-BARR-VIRUS (EBV) DNA IN SALIVA AND EBV SEROLOGY OF HIV-1-INFECTED PERSONS WITH AND WITHOUT HAIRY LEUKOPLAKIA [J].
LUCHT, E ;
BIBERFELD, P ;
LINDE, A .
JOURNAL OF INFECTION, 1995, 31 (03) :189-194
[27]   CARDIAC MORBIDITY AND RELATED MORTALITY IN CHILDREN WITH HIV-INFECTION [J].
LUGINBUHL, LM ;
ORAV, EJ ;
MCINTOSH, K ;
LIPSHULTZ, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (22) :2869-2875
[28]   ASSOCIATION OF EPSTEIN-BARR-VIRUS WITH LEIOMYOSARCOMAS IN YOUNG-PEOPLE WITH AIDS [J].
MCCLAIN, KL ;
LEACH, CT ;
JENSON, HB ;
JOSHI, VV ;
POLLOCK, BH ;
PARMLEY, RT ;
DICARLO, FJ ;
CHADWICK, EG ;
MURPHY, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (01) :12-18
[29]   PROLONGED OROPHARYNGEAL EXCRETION OF EPSTEIN-BARR VIRUS AFTER INFECTIOUS MONONUCLEOSIS [J].
MILLER, G ;
NIEDERMA.JC ;
ANDREWS, LL .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (05) :229-232
[30]   SOLUBLE RECOMBINANT CR-2 (CD21) INHIBITS EPSTEIN-BARR VIRUS-INFECTION [J].
NEMEROW, GR ;
MULLEN, JJ ;
DICKSON, PW ;
COOPER, NR .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1348-1352